When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Patients that have been diagnosed with breast cancer often end up with a cumbersome amount of appointments with their physicians and specialists. Many of these doctor visits could…
Incorporating elements of telemedicine into a traditional practice can improve a physician’s work-life balance while simultaneously improving their patients’ experiences. There are many patient appointments that don’t necessarily…
John Papandrea, CEO of Willowglade Technologies, discusses some of the major frustrations breast cancer sufferers experience aside from their actual diagnosis. Willowglade has recently created a smartphone application…
Rebecca Kaltman, MD, oncologist and founder of Breast Cancer Consultants, explains why telemedicine is increasingly being embraced by both patients and specialist practitioners. In terms of cancer treatment,…
Each year, more than one and a half million women in the United States undergo a breast biopsy. After a breast biopsy, a pathologist evaluates the tissue to…
Patients diagnosed with Acute Lymphoblastic Leukemia, the most common form of childhood cancer, are typically given Vincristine, a very powerful chemotherapy drug with a high toxicity called neuropathy…
Using an MRI, doctors are able to detect prostate cancer more effectively than the a traditional biopsy, which uses ultrasound technology. According to a study published in JAMA,…
Every year, thousands of women are diagnosed with breast cancer. Even among women with small breast cancers, survival rates vary greatly between women of different ethnicities. A study…
On October 13, 2014 the Metastatic Breast Cancer Alliance revealed the results of an analysis that identified 169 new target therapies under development for the treatment of metastatic…
Karen Shayne, Co-Founder, Women Survivors Alliance, talks about when a woman has survived her cancer, and what’s next for her life. The Women Survivors Alliance aims to help women…
